Establishment Labs Holdings, Inc. (ESTA)
65.93
-0.04
(-0.06%)
USD |
NASDAQ |
Sep 28, 15:07
Establishment Labs Holdings Research and Development Expense (TTM) : 20.33M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 20.33M |
| March 31, 2026 | 20.43M |
| December 31, 2025 | 20.25M |
| September 30, 2025 | 19.96M |
| June 30, 2025 | 20.20M |
| March 31, 2025 | 20.49M |
| December 31, 2024 | 19.71M |
| September 30, 2024 | 20.38M |
| June 30, 2024 | 22.71M |
| March 31, 2024 | 24.17M |
| December 31, 2023 | 26.43M |
| September 30, 2023 | 27.09M |
| June 30, 2023 | 25.25M |
| March 31, 2023 | 23.20M |
| December 31, 2022 | 20.27M |
| September 30, 2022 | 19.82M |
| Date | Value |
|---|---|
| June 30, 2022 | 18.42M |
| March 31, 2022 | 17.86M |
| December 31, 2021 | 18.32M |
| September 30, 2021 | 16.75M |
| June 30, 2021 | 15.59M |
| March 31, 2021 | 13.64M |
| December 31, 2020 | 13.79M |
| September 30, 2020 | 12.96M |
| June 30, 2020 | 14.00M |
| March 31, 2020 | 15.61M |
| December 31, 2019 | 14.99M |
| September 30, 2019 | 15.02M |
| June 30, 2019 | 14.42M |
| March 31, 2019 | 14.12M |
| December 31, 2018 | 12.69M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| PROCEPT BioRobotics Corp. | 77.19M |
| Abbott Laboratories | 3.128B |
| AngioDynamics, Inc. | 29.45M |
| Alphatec Holdings, Inc. | 76.69M |
| AtriCure, Inc. | 94.05M |